本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Collegium Pharmaceutical, Inc.

22.81
+0.06000.26%
盤後22.810.00000.00%18:03 EDT
成交量:82.55萬
成交額:1,884.91萬
市值:7.43億
市盈率:17.96
高:23.19
開:22.80
低:22.50
收:22.75
52周最高:50.79
52周最低:22.50
股本:3,255.56萬
流通股本:3,136.51萬
量比:0.89
換手率:2.63%
股息:- -
股息率:- -
每股收益(TTM):1.27
每股收益(LYR):1.73
淨資產收益率:17.61%
總資產收益率:5.75%
市淨率:2.38
市盈率(LYR):13.18

資料載入中...

2025/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/06

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/27

重要事件披露

Form 8-K - Current report
2025/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/05

重要事件披露

Form 8-K - Current report
2025/01/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/08

重要事件披露

Form 8-K - Current report
2024/11/15

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/11/13

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/09/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities